There has been a marked increase in the amount of money being invested by Chinese investors into U.S. early stage biotechnology companies since 2017, spurred on by direct encouragement from Beijing through its Made in China...more
11/2/2018
/ Acquisitions ,
Biotechnology ,
CFIUS ,
China ,
Federal Pilot Programs ,
FIRRMA ,
Foreign Direct Investment ,
Foreign Investment ,
Medical Devices ,
Mergers ,
NDRC ,
Outbound Transactions